Kevin Judice rolls South San Francisco biotech Dice toward a $100M IPO
The company could push its first drug into an early-stage clinical trial for psoriasis within months.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Ron Leuty Source Type: news